RPO LLC’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

RPO LLC’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-359,009	Closed	-$3.63M	–	215
2022 Q4	$3.63M	Sell	359,009 -20,012	-5%	-$200K	1.24%	27
2022 Q3	$3.76M	Sell	379,021 -249,582	-40%	-$2.47M	0.91%	36
2022 Q2	$6.22M	Buy	628,603 +458,817	+270%	+$4.5M	1.56%	27
2022 Q1	$1.67M	Buy	+169,786	New	+$1.67M	0.54%	58

RPO LLC's BIOT Position: Q1 2023 in Review

RPO LLC sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 359,009 shares — an estimated $3.63M sold.

RPO LLC first reported a position in BIOT in Q1 2022 and held it in 4 quarters. The position peaked at $6.22M in Q2 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

RPO LLC reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
RPO LLC sold 359,009 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $3.63M.
RPO LLC first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q1 2022 and held it in 4 quarters.
RPO LLC's Biotech Acquisition Company Class A Ordinary Shares position peaked at $6.22M in Q2 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on RPO LLC's 13F filing for Q1 2023, filed 11 May 2023.